SCHEMBL21788104

SCHEMBL21788104

Cc1cc(-c2ccccc2)ccc1N(N)c1ccc2c(c1)C(C)(C)c1ccccc1-2

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PDK2 Q15119 15/20 0.36
▸ PGR P06401 1/20 0.31
▸ MEN1 O00255 1/20 0.31
▸ APAF1 O14727 1/20 0.31
▸ NPC1 O15118 1/20 0.31
▸ LMNA P02545 1/20 0.31
▸ MAPT P10636 1/20 0.31
▸ THRB P10828 1/20 0.31
▸ XBP1 P17861 1/20 0.31
▸ PTBP1 P26599 1/20 0.31
▸ HTT P42858 1/20 0.31
▸ RAB9A P51151 1/20 0.31
▸ GALK1 P51570 1/20 0.31
▸ BLM P54132 1/20 0.31
▸ SMAD3 P84022 1/20 0.31
▸ KMT2A Q03164 1/20 0.31
▸ ATM Q13315 1/20 0.31
▸ SMN1; SMN2 Q16637 1/20 0.31
▸ NPSR1 Q6W5P4 1/20 0.31
▸ L3MBTL1 Q9Y468 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21763424 0.89 PDK2 (0.37) PDK2PGRMEN1APAF1NPC1
SCHEMBL22568038 0.89 PDK2 (0.39) PDK2PGRMEN1APAF1NPC1
SCHEMBL22517388 0.89 PDK2 (0.39) PDK2PGRMEN1APAF1NPC1
SCHEMBL22568039 0.88 PDK2 (0.38) PDK2PGRMEN1APAF1NPC1
SCHEMBL22567748 0.88 PDK2 (0.38) PDK2PGRMEN1APAF1NPC1
SCHEMBL19533142 0.88 PDK2 (0.38) PDK2PGRMEN1APAF1NPC1
SCHEMBL16922888 0.88 PDK2 (0.38) PDK2PGRMEN1APAF1NPC1
SCHEMBL21763021 0.88 PDK2 (0.38) PDK2MEN1APAF1NPC1LMNA
SCHEMBL22567858 0.86 PDK2 (0.37) PDK2PGRMEN1APAF1NPC1
SCHEMBL24177627 0.86 PDK2 (0.37) PDK2PGRNPC1MAPTRAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20220006020-A1 DI-, TRI- AND TETRAPHENYLINDANE DERIVATES AND THEIR USE IN ORGANIC ELECTRONICS DOTTIKON ES HOLDING AG (CH) 2022-01-06 — — US disclosed
EP-3650438-A1 DI-, TRI- AND TETRAPHENYLINDANE DERIVATIVES AND THEIR USE IN ORGANIC ELECTRONICS DOTTIKON ES HOLDING AG (CH) 2020-05-13 — — EP disclosed
US-20200075862-A1 INDANE DERIVATIVES AND THEIR USE IN ORGANIC ELECTRONICS DOTTIKON ES HOLDING AG (CH) 2020-03-05 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220006020-A1 DI-, TRI- AND TETRAPHENYLINDANE DERIVATES AND THEIR USE IN ORGANIC ELECTRONICS NR0B2, KCNJ2, TRRAP PDK2 1160/4885PGR 731/4885MEN1 2154/4885
US-20200075862-A1 INDANE DERIVATIVES AND THEIR USE IN ORGANIC ELECTRONICS KCNJ2, KCNA2, CYP2J2 PDK2 1400/4885PGR 378/4885MEN1 2274/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback